EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High‐Dimensional Immunophenotyping of Post‐COVID‐19 and Post‐Influenza Patients Reveals Persistent and Specific Immune Signatures After Acute Respiratory Infection

Francisco Pérez-Cózar, Paloma Cal-Sabater, Paulina Rybakowska, Elisa Arribas-Rodríguez, Aida Fiz-López, Antonio García-Blesa, Juan Hernández, Sara Gutiérrez, Pablo Tellería, Cristina Novoa, Silvia Rojo Rello, Ángel De Prado und 15 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Francisco Pérez-Cózar und 26 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Pfizer/University of Granada/Andalusian Regiona…. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study has been funded through Programa Estratégico Instituto de Biomedicina y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485), Junta de….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐term consequences of SARS‐CoV‐2 infection are unknown since recovered individuals can experience symptoms and latent viral reactivation for months. Indeed, acute post‐infection sequelae have also been observed in other respiratory viral infections, including influenza. To characterize post‐COVID‐19 and post‐influenza induced alterations to the cellular immunome, peripheral blood mononuclear cells (PBMCs) were obtained from patients 3 months after recovery from COVID‐19 ( n = 93) or influenza ( n = 25), and from pre‐pandemic healthy controls ( n = 25). PBMCs were characterized using a 40‐plex mass cytometry panel. Principal component analysis (PCA), classification models, and K‐means clustering were subsequently applied. PCA identified distinct immune profiles between cohorts, with both post‐COVID and post‐flu patients displaying an altered chemokine receptor expression compared to pre‐pandemic healthy controls. These alterations were more prominent in post‐COVID patients since they exhibited highly increased expression of chemokine receptors CXCR3 and CCR6 by various lymphoid populations, while post‐influenza patients mainly showed a decrease in CCR4 expression by naïve T cells, monocytes, and conventional dendritic cells. Classification models using immunophenotyping data confirm the three groups, while K‐means clustering revealed two subgroups among post‐COVID patients, with younger patients showing more pronounced immune alterations in the chemokine receptor profile, independently of long COVID symptoms. In conclusion, post‐COVID and post‐influenza patients exhibit distinct and unique persistent immune alterations. Understanding these altered immune profiles can guide targeted therapies for post‐COVID syndrome and highlight differences in immune recovery from various respiratory infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza, HumanRespiratory Tract InfectionsHumansMaleMiddle AgedFemaleImmunophenotypingAdultAgedLeukocytes, MononuclearSARS-CoV-2Post-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

immune signatureimmunomepost‐COVID‐19post‐influenza

Autor:innen und Institutionen

  • Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
  • Mucosal Immunology Lab. Institute of Biomedicine and Molecular Genetics (IBGM, University of Valladolid-CSIC), Valladolid, Spain.
  • Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Microbiology Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Microbiology Department, Hospital Universitario Rio Hortega, Valladolid, Spain.
  • Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

ORCID-Profile: Sara Cuesta-Sancho

Förderung

  • This study has been funded through Programa Estratégico Instituto de Biomedicina y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485), Junta de…

Zitieren

APA

Pérez-Cózar, F., Cal-Sabater, P., Rybakowska, P., Arribas-Rodríguez, E., Fiz-López, A., García-Blesa, A., Hernández, J., Gutiérrez, S., Tellería, P., Novoa, C., Rello, S. R., De Prado, Á., Pérez, C., Sedano, R., Domínguez-Gil, M., Peñarrubia, M. J., Pieren, D. K. J., Garrote, J. A., Arranz, E., …, & Cuesta-Sancho, S. (2025). High‐Dimensional Immunophenotyping of Post‐COVID‐19 and Post‐Influenza Patients Reveals Persistent and Specific Immune Signatures After Acute Respiratory Infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.70435

Vancouver

Pérez-Cózar F, Cal-Sabater P, Rybakowska P, Arribas-Rodríguez E, Fiz-López A, García-Blesa A, et al. High‐Dimensional Immunophenotyping of Post‐COVID‐19 and Post‐Influenza Patients Reveals Persistent and Specific Immune Signatures After Acute Respiratory Infection. Journal of Medical Virology. 2025. doi:10.1002/jmv.70435

BibTeX
@article{PrezCzar2025,
  author = {Pérez-Cózar, Francisco and Cal-Sabater, Paloma and Rybakowska, Paulina and Arribas-Rodríguez, Elisa and Fiz-López, Aida and García-Blesa, Antonio and Hernández, Juan and Gutiérrez, Sara and Tellería, Pablo and Novoa, Cristina and Rello, Silvia Rojo and De Prado, Ángel and Pérez, Cándido and Sedano, Rosa and Domínguez-Gil, Marta and Peñarrubia, María Jesús and Pieren, Daan K J and Garrote, José A and Arranz, Eduardo and Eiros, José María and Tamayo, Eduardo and Orduña, Antonio and van Els, Cécile A C M and Dueñas, Carlos and Marañón, Concepción and Bernardo, David and Cuesta-Sancho, Sara},
  title = {High‐Dimensional Immunophenotyping of Post‐COVID‐19 and Post‐Influenza Patients Reveals Persistent and Specific Immune Signatures After Acute Respiratory Infection},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70435}
}
Kostenlos starten →